Quarterly report · Q2
3645.TEDINET S100SMIQ
Period2023-06-01 → 2023-11-30
Filed2024-01-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥4.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥170m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥178m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥194m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥205m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥192m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥207m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥116m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥116m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥126m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥130m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥3.6bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥3.4bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥131m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥429m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥59m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥62m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥32m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥18m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥906,000 | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥12.8 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.39 | 2023-09-01 → 2023-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.97 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.09 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.36 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥315m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥7m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥68m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥390m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥392m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥2,000 |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥297m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥12,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥25m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥213,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥51m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥374m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥376m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Amortization of goodwill ope cf | Prior1YTDDuration | 22971000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 15202000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -4285000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 3908000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -378000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -708000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 1528000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 2170000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | 4269000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YTDDuration | -1631000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | -2552000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -21420000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -25189000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 5988000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -129768000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -66657000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -99976000 | JPY |
| Decrease increase in prepaid expenses ope cf | Prior1YTDDuration | -31035000 | JPY |
| Decrease increase in prepaid expenses ope cf | CurrentYTDDuration | -10314000 | JPY |
| Decrease increase in long term prepaid expenses ope cf | Prior1YTDDuration | 18727000 | JPY |
| Decrease increase in long term prepaid expenses ope cf | CurrentYTDDuration | 24352000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 61314000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 25334000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -53536000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -41811000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | -8602000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -10797000 | JPY |
| Other net ope cf | Prior1YTDDuration | 5432000 | JPY |
| Other net ope cf | CurrentYTDDuration | -697000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 142976000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -45293000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 378000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 708000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -1528000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -2170000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -82380000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -84145000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 59445000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -130900000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -5263000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -12320000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 1631000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 2552000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -20000000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | － | JPY |
| Payments of loans receivable inv cf | Prior1YTDDuration | － | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | -3000000 | JPY |
| Collection of loans receivable inv cf | Prior1YTDDuration | 1678000 | JPY |
| Collection of loans receivable inv cf | CurrentYTDDuration | 1695000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |